NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:30
NeurAxis Market Cap : 77.43M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 76.18M |
| November 04, 2026 | 85.53M |
| November 03, 2026 | 82.04M |
| November 02, 2026 | 82.29M |
| October 30, 2026 | 88.90M |
| October 29, 2026 | 94.13M |
| October 28, 2026 | 94.38M |
| October 27, 2026 | 91.77M |
| October 26, 2026 | 90.39M |
| October 23, 2026 | 92.26M |
| October 22, 2026 | 94.76M |
| October 21, 2026 | 98.75M |
| October 20, 2026 | 97.50M |
| October 19, 2026 | 97.87M |
| October 16, 2026 | 96.00M |
| October 15, 2026 | 96.50M |
| October 14, 2026 | 81.42M |
| October 13, 2026 | 81.04M |
| October 12, 2026 | 83.79M |
| October 09, 2026 | 86.40M |
| October 08, 2026 | 84.41M |
| October 07, 2026 | 85.16M |
| October 06, 2026 | 84.53M |
| October 05, 2026 | 89.15M |
| October 02, 2026 | 88.65M |
| Date | Value |
|---|---|
| October 01, 2026 | 89.40M |
| September 30, 2026 | 91.89M |
| September 29, 2026 | 96.75M |
| September 28, 2026 | 92.26M |
| September 25, 2026 | 94.26M |
| September 24, 2026 | 96.63M |
| September 23, 2026 | 91.14M |
| September 22, 2026 | 91.14M |
| September 21, 2026 | 89.02M |
| September 18, 2026 | 94.88M |
| September 17, 2026 | 95.13M |
| September 16, 2026 | 86.53M |
| September 15, 2026 | 71.07M |
| September 14, 2026 | 71.69M |
| September 11, 2026 | 71.57M |
| September 10, 2026 | 70.94M |
| September 09, 2026 | 71.44M |
| September 08, 2026 | 73.69M |
| September 04, 2026 | 74.31M |
| September 03, 2026 | 75.68M |
| September 02, 2026 | 74.19M |
| September 01, 2026 | 72.44M |
| August 31, 2026 | 74.93M |
| August 28, 2026 | 74.81M |
| August 27, 2026 | 75.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 192.90B |
| AngioDynamics, Inc. | 498.27M |
| Alphatec Holdings, Inc. | 1.151B |
| AtriCure, Inc. | 3.021B |
| Baxter International, Inc. | 13.17B |
Market Cap Related Metrics
| PS Ratio | 12.73 |
| Price to Book Value | 11.50 |
| Price | 6.21 |
| Earnings Yield | -12.56% |